[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Bristol-Myers Squibb Co Graphic](https://lunarcrush.com/gi/w:26/t:$bmy.png) Bristol-Myers Squibb Co (BMY)

Bristol-Myers Squibb to acquire Orbital Therapeutics for $1.5B.  SystImmune and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren an EGFR x HER3 Bispecific Antibody-Drug Conjugate in Patients with Advanced Solid Tumors at ESMO 2025.

### About Bristol-Myers Squibb Co
Bristol-Myers Squibb Co. (BMY) is a pharmaceutical company.  
Bristol-Myers Squibb Co uses the ticker $BMY for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$bmy/insights)
- Bristol-Myers Squibb Co (BMY) social dominance is up XXXXX% from the previous week.
- Bristol-Myers Squibb Co (BMY) galaxy score™ is up XXXXX% from the previous month.

### Price: $XXXXX [#](/topic/$bmy/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/close.tsv)  
The current price of $XXXXX is likely influenced by a mix of positive and negative factors. The positive sentiment, analyst recommendations, and recent developments are likely supporting the price. However, concerns about market pressure and negative news may be limiting the upside potential.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| XXXX%   | -XXXX% | -XXXX% |

**1-Year High**: $XXXXX on 2025-03-10  
**1-Year Low**: $XXXXX on 2025-07-31  
  
  
### AltRank: XXXXX [#](/topic/$bmy/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/alt_rank.tsv)  
Bristol-Myers Squibb Co (BMY) is currently AltRank #1,153 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX -XXX  
**1 Month**: XXXXX -XXX  
**6 Months**: XXXXX +991  
**1 Year**: XXXXX +667  
**1-Year High**: XXXXX on 2025-08-24  
**1-Year Low**: XX on 2025-08-01  
  
  
### Galaxy Score: XX [#](/topic/$bmy/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XX +12  
**1 Month**: XX +25  
**6 Months**: XX -XX  
**1 Year**: XX -X  
**1-Year High**: XX on 2025-07-16  
**1-Year Low**: XX on 2024-12-09  
  
  
### Engagements: XXXXXX [#](/topic/$bmy/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX -XX%  
**1 Month**: XXXXXXXXX +44%  
**6 Months**: XXXXXXXXXX +24%  
**1 Year**: XXXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-02-06  
**1-Year Low**: XXXXX on 2025-09-17  

| Social Network | X      | YouTube | News | Reddit | TikTok |
| -------------- | -      | ------- | ---- | ------ | ------ |
| Engagements    | XXXXXX | XXXXX   | XX   | XXX    | XX     |
  

  
  
### Mentions: XXX [#](/topic/$bmy/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXXXX -XX%  
**6 Months**: XXXXXX +37%  
**1 Year**: XXXXXX -XX%  
**1-Year High**: XXXXX on 2025-06-27  
**1-Year Low**: XX on 2025-09-17  

| Social Network | X   | YouTube | News | Reddit | TikTok |
| -------------- | -   | ------- | ---- | ------ | ------ |
| Mentions       | XXX | XXX     | XX   | XX     | XX     |
  

  
  
### Creators: XXX [#](/topic/$bmy/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Bristol-Myers Squibb Co (BMY) in the last XX hours which is down XX% from XXX in the previous XX hours
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXXX +144%  
**1 Year**: XXXXXX +119%  
**1-Year High**: XXXXX on 2025-06-27  
**1-Year Low**: XX on 2025-09-17  

The most influential creators that mention Bristol-Myers Squibb Co in the last XX hours

| Creator                                                    | Rank | Followers | Posts | Engagements |
| -------                                                    | ---- | --------- | ----- | ----------- |
| [@bristolmyerssquibb](/creator/youtube/bristolmyerssquibb) | X    | XXXXX     | XX    | XXXXX       |
| [@Prof_Oak_](/creator/twitter/Prof_Oak_)                   | X    | XXXXXX    | X     | XXXXX       |
| [@yaireinhorn](/creator/twitter/yaireinhorn)               | X    | XXXXXX    | X     | XXXXX       |
| [@A1PHAEDGE](/creator/twitter/A1PHAEDGE)                   | X    | XXX       | X     | XXX         |
| [@bioinvestor24](/creator/twitter/bioinvestor24)           | X    | XXXXX     | X     | XXX         |
| [@Elisabe66802172](/creator/twitter/Elisabe66802172)       | X    | XXX       | X     | XXX         |
| [@FierceBiotech](/creator/twitter/FierceBiotech)           | X    | XXXXXXX   | X     | XXX         |
| [@bmsnews](/creator/twitter/bmsnews)                       | X    | XXXXXXX   | X     | XXX         |
| [@BIOTECHSCANNER](/creator/twitter/BIOTECHSCANNER)         | X    | XXXXX     | X     | XXX         |
| [@AponiaAnalytics](/creator/twitter/AponiaAnalytics)       | XX   | XXXXX     | X     | XXX         |

[View More](/list/creators/$bmy/100)
  
  
### Sentiment: XX% [#](/topic/$bmy/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +6%  
**1 Month**: XX% +31%  
**6 Months**: XX% +26%  
**1 Year**: XX% +10%  
**1-Year High**: XX% on 2025-06-27  
**1-Year Low**: XX% on 2025-05-15  

**Most Supportive Themes**
- **Positive Sentiment and Stock Recommendations:** (31%) Posts express positive sentiment towards BMY, with recommendations to buy the stock. This theme is supported by high engagement posts.
- **Company News and Developments:** (15%) Posts highlight positive developments such as FDA fast track designation for a drug. This theme is supported by news articles and high engagement.
- **Analyst Ratings and Price Targets:** (15%) Posts cite analyst ratings and price targets, with some analysts recommending a 'Buy' rating. This theme is supported by high engagement posts.
  
**Most Critical Themes**
- **Negative News and Market Pressure:** (20%)  Some posts mention negative news, such as potential job losses and the impact of tariffs. This theme is supported by a few posts.
- **General Market Concerns:** (5%)  Some posts discuss broader market concerns, such as the impact of Trump's policies on the pharmaceutical industry. This theme is supported by a few posts.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXXX   | XX% | XXXXXX  | XX% | XXX      | X% |
| YouTube | XXXXX    | XX% | XXX     | X%  | XXXXX    | X% |
| News    | XX       | X%  | XX      | X%  | X        | X% |
| Reddit  | XX       | X%  | XX      | X%  | XX       | X% |
| TikTok  | XX       | X%  | XX      | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXX    | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$bmy/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXX%  
**1 Week**: XXXXX% +0.016%  
**1 Month**: XXXXX% +0.019%  
**6 Months**: XXXXX% -XXXXX%  
**1 Year**: XXXXX% -XXXX%  
**1-Year High**: XXXXX% on 2025-06-27  
**1-Year Low**: XXXXX% on 2025-09-17  
  
  
### Market Dominance: XXXXX% [#](/topic/$bmy/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXX% on 2025-03-12  
**1-Year Low**: XXXXX% on 2025-10-18  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/$bmy/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$bmy/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$bmy/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX -$0.50%  
**1 Month**: $XXXXXXXXXXXXXX -$4.30%  
**6 Months**: $XXXXXXXXXXXXXX -$11%  
**1 Year**: $XXXXXXXXXXXXXX -$18%  
**1-Year High**: $XXXXXXXXXXXXXXX on 2025-03-10  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-07-31  

**Top assets mentioned**
In the posts about Bristol-Myers Squibb Co in the last XX hours

[Pfizer, Inc. (PFE)](/topic/$pfe)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[AbbVie Inc (ABBV)](/topic/$abbv)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[AstraZeneca PLC (AZN)](/topic/$azn)
[Johnson & Johnson (JNJ)](/topic/johnson-johnson)
[Bitcoin Incognito (XBI)](/topic/$xbi)
[Cytokinetics Inc. (CYTK)](/topic/$cytk)
[Amgen, Inc. (AMGN)](/topic/$amgn)

**Top topics mentioned**
In the posts about Bristol-Myers Squibb Co in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$pfe](/topic/$pfe), [$mrk](/topic/$mrk), [stocks financial services](/topic/stocks-financial-services), [stocks consumer defensive](/topic/stocks-consumer-defensive), [stocks technology](/topic/stocks-technology), [$15b](/topic/$15b), [stocks](/topic/stocks), [vivo](/topic/vivo), [$abbv](/topic/$abbv), [eli lilly](/topic/eli-lilly), [acquisition](/topic/acquisition), [investment](/topic/investment), [stocks communication services](/topic/stocks-communication-services), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks industrials](/topic/stocks-industrials), [$azn](/topic/$azn), [johnson johnson](/topic/johnson-johnson), [$xbi](/topic/$xbi), [$cytk](/topic/$cytk), [$amgn](/topic/$amgn), [sanofi](/topic/sanofi), [novartis](/topic/novartis), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$nvo](/topic/$nvo), [$ibb](/topic/$ibb), [$prta](/topic/$prta), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$beam](/topic/$beam), [gilead sciences](/topic/gilead-sciences), [$jnj](/topic/$jnj), [coins base ecosystem](/topic/coins-base-ecosystem), [$ptgx](/topic/$ptgx), [$ko](/topic/$ko), [united states](/topic/united-states), [money](/topic/money), [$pep](/topic/$pep), [$ewtx](/topic/$ewtx), [$tmus](/topic/$tmus), [$cjet](/topic/$cjet), [market cap](/topic/market-cap), [coins defi](/topic/coins-defi), [$ryzb](/topic/$ryzb), [targets](/topic/targets), [behind the](/topic/behind-the), [$tmo](/topic/$tmo), [$novnsw](/topic/$novnsw), [launches](/topic/launches), [employees](/topic/employees), [$unh](/topic/$unh), [$vktx](/topic/$vktx), [$bkng](/topic/$bkng), [$tjx](/topic/$tjx), [$incy](/topic/$incy), [coins bsc](/topic/coins-bsc), [$isrg](/topic/$isrg), [$pypl](/topic/$pypl), [has been](/topic/has-been), [jersey](/topic/jersey), [boston](/topic/boston), [$issc](/topic/$issc), [royal bank of canada](/topic/royal-bank-of-canada), [$tgtx](/topic/$tgtx), [$exel](/topic/$exel), [$spy](/topic/$spy), [procter gamble](/topic/procter-gamble), [india](/topic/india), [stocks energy](/topic/stocks-energy), [novo](/topic/novo), [$ipsc](/topic/$ipsc), [$lly](/topic/$lly), [biogen inc](/topic/biogen-inc), [$377m](/topic/$377m), [$444m](/topic/$444m), [arthur](/topic/arthur), [hosted](/topic/hosted), [$iova](/topic/$iova), [$maji](/topic/$maji), [nu holdings](/topic/nu-holdings), [cuts](/topic/cuts), [coins dao](/topic/coins-dao), [donald trump](/topic/donald-trump), [stockmarket](/topic/stockmarket), [$cmcsa](/topic/$cmcsa), [$crsp](/topic/$crsp), [stuck in](/topic/stuck-in), [$nvs](/topic/$nvs), [ticker](/topic/ticker), [beam beam therapeutics inc](/topic/beam-beam-therapeutics-inc), [future of](/topic/future-of), [momentum](/topic/momentum), [$prme](/topic/$prme), [$bpmc](/topic/$bpmc), [$qcom](/topic/$qcom), [$aapl](/topic/$aapl), [$barcl](/topic/$barcl), [$krtx](/topic/$krtx), [$tak](/topic/$tak), [$gild](/topic/$gild), [discount](/topic/discount)

### Top News [#](/topic/$bmy/news)
---
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Stock Looks Undervalued As Bristol Myers Buys Orbital Therapeutics (NYSE:BMY) Seeking Alpha"  
[News Link](https://seekingalpha.com/article/4829435-bristol-myers-stock-looks-undervalued-as-buys-orbital-therapeutics) [@SeekingAlpha](/creator/x/SeekingAlpha) 2025-10-13T14:18Z 309.7K followers, XXX engagements


"SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration"  
[News Link](https://www.prnewswire.com/news-releases/systimmune-to-receive-milestone-payment-from-bristol-myers-squibb-under-iza-bren-collaboration-302580982.html) [@abcnews](/creator/x/abcnews) 2025-10-13T09:02Z 208.1M followers, XXX engagements



### Top Social Posts [#](/topic/$bmy/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$MRK phase X in platinum refractory OC today. Big improvement with pembro of X months OS when added to wkly taxol and avastin ( rivals FR ADC data $ABBV ) OS improvement much better than PFS as expected with PD1. Suggests to me adding other proven to work immune mechanisms such as Bispecific PD1-CTLA4 may enhance OS in several settings ( since $BMY used subtherapeutic ipilimumab in most of its trials ) Vs PD1 -VEGF that primarily improves PFS $SMMT with marginal impact on OS $MGNX Pd1 CTLA4 one of the most advanced of this class and in ovarian cancer trial. It could report positive PFS in"  
[X Link](https://x.com/bioinvestor24/status/1979586142745059736) [@bioinvestor24](/creator/x/bioinvestor24) 2025-10-18T16:31Z 4390 followers, 1787 engagements


"🔹 We are honored to announce Bristol Myers Squibb as our Gold Sponsor for the 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference Together we are driving innovation in health economics and outcomes research. Register now to attend the conference: #ISPOR_Saudi25 #PEOR25"  
[X Link](https://x.com/sa_ispor/status/1979572502289334536) [@sa_ispor](/creator/x/sa_ispor) 2025-10-18T15:37Z 2869 followers, XXX engagements


"Bristol Myers Squibb to Present Data at ESMO 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types"  
[Reddit Link](https://redd.it/1o5gmyz) [@Quantisnow](/creator/reddit/Quantisnow) 2025-10-18T04:45Z X followers, X engagements


"SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration"  
[Reddit Link](https://redd.it/1o5eoem) [@Quantisnow](/creator/reddit/Quantisnow) 2025-10-18T04:45Z X followers, X engagements